Skip to main content
PhD DegreeFaculty of Faculty of Medical, Health & Clinical SciencesPharmacy

Ph.D. in Pharmaceutical Sciences: Molecular Pharmacology & Nanomedicine

Master Advanced Research Methodology (PhD Pharmacy) in University - Pharmacy with this structured course, covering 8 modules and practice assessments.

Instructor
Created by PAMCET Learning Team
advanced1 weekEnglish

Course Overview

Master Advanced Research Methodology (PhD Pharmacy) in University - Pharmacy with this structured course, covering 8 modules and practice assessments. Curriculum Structure & Core Modules: • 1. PMSC 901: Computational Molecular Dynamics & In Silico Drug Design • 2. PMSC 902:...

What You'll Learn

  • Understand and apply the principles of Philosophy of Pharmacy Research at Doctoral Level
  • Work confidently through Epistemology in Pharmacy and its practical applications
  • Analyse real-world scenarios involving Advanced Quantitative Methods (PhD Pharmacy)
  • Develop applied skills in Advanced Laboratory Methods (PhD Pharmacy)
  • Critically evaluate approaches to Advanced Clinical Research Methods (PhD Pharmacy)

Requirements

  • Prior coursework or practical experience in University - Pharmacy is recommended before starting this course
  • A computer, tablet or smartphone with a stable internet connection
  • Willingness to commit regular study time to complete lessons, quizzes and assignments

Degree Programme Curriculum Context

This course is a curriculum unit of the PhD in Pharmacy degree framework in Nigeria.

Earn Your Certificate

Showcase your skills with a certificate! Complete the course, submit your project, and earn your certificate. Here's a sample of what you'll receive to show off your accomplishments.

course-certificate
Lecture Board & Syllabus

Course Curriculum

Browse complete theoretical foundations, worked calculations, laboratory protocols, and board assessment questions under each topic.

Launch Course Reader →
8 Chapters
•
24 Lecture
•
0s
Subtopic 1Document LectureOpen Access~47 min read

All-Atom Molecular Dynamics Simulations, CHARMM/AMBER Force Fields, and Free Energy Perturbation (FEP)

Ph.D. in Pharmaceutical Sciences Chapter 1: PMSC 901: Computational Molecular Dynamics & In Silico Drug Design Lecture 1 All-Atom Molecular Dynamics Simulations, CHARMM/AMBER Force Fields, and Free Energy Perturbation (FEP) Doctoral investigation into Newtonian equations of motion, empirical potential energy functions, periodic boundary conditions, particle mesh Ewald electrostatics, and alchemica...

Module 1 • Subtopic 1•39,325 characters of authentic academic content
Subtopic 2Document Lecture

Quantum Mechanics/Molecular Mechanics (QM/MM) Hybrid Simulations of Enzymatic Catalysis and Covalent Inhibition

Ph.D. in Pharmaceutical Sciences Chapter 1: PMSC 901: Computational Molecular Dynamics & In Silico Drug Design Lecture 2 Quantum Mechanics/Molecular Mechanics (QM/MM) Hybrid Simulations of Enzymatic Catalysis and Covalent Inhibition Rigorous multi-scale quantum chemical and classical mechanical modeling of enzymatic transition states, covalent drug warhead attack mechanisms, link atom boundary tre...

Module 1 • Subtopic 2
Subtopic 3Document Lecture

Structure-Based Virtual Screening, Pharmacophore De Novo Design, and Deep Learning Generative Chemistry (Diffusion Models)

Ph.D. in Pharmaceutical Sciences Chapter 1: PMSC 901: Computational Molecular Dynamics & In Silico Drug Design Lecture 3 Structure-Based Virtual Screening, Pharmacophore De Novo Design, and Deep Learning Generative Chemistry (Diffusion Models) Doctoral synthesis of ultra-large chemical space docking, 3D pharmacophore interaction fields, graph neural networks (GNNs), SE(3)-equivariant diffusion mod...

Module 1 • Subtopic 3
Subtopic 1Document Lecture

Supramolecular Biomaterials, Stimuli-Responsive Polymers (pH, Redox, Thermal, Enzymatic Cleavage), and Hydrogels

Ph.D. in Pharmaceutical Sciences Chapter 2: PMSC 902: Advanced Nanobiomaterials & Stimuli-Responsive Drug Delivery Lecture 4 Supramolecular Biomaterials, Stimuli-Responsive Polymers (pH, Redox, Thermal, Enzymatic Cleavage), and Hydrogels Doctoral investigation of non-covalent supramolecular polymers, dynamic host-guest chemistry, sol-gel phase transitions, redox-triggered glutathione cleavage, and...

Module 2 • Subtopic 1
Subtopic 2Document Lecture

Lipid Nanoparticles (LNPs), Ionizable Lipids, Endosomal Escape Biophysics, and mRNA/siRNA Delivery

Ph.D. in Pharmaceutical Sciences Chapter 2: PMSC 902: Advanced Nanobiomaterials & Stimuli-Responsive Drug Delivery Lecture 5 Lipid Nanoparticles (LNPs), Ionizable Lipids, Endosomal Escape Biophysics, and mRNA/siRNA Delivery Doctoral formulation of four-component lipid nanoparticles, ionizable lipid pKa optimization, microfluidic hydrodynamic focusing, endosomal membrane inverted hexagonal (H_II) p...

Module 2 • Subtopic 2
Subtopic 3Document Lecture

Exosomes, Cell-Membrane Camouflaged Nanocarriers, and Active Cell-Targeting Biointerfaces

Ph.D. in Pharmaceutical Sciences Chapter 2: PMSC 902: Advanced Nanobiomaterials & Stimuli-Responsive Drug Delivery Lecture 6 Exosomes, Cell-Membrane Camouflaged Nanocarriers, and Active Cell-Targeting Biointerfaces Doctoral analysis of natural extracellular vesicles, erythrocyte/macrophage/platelet membrane extrusion, CD47 "don't eat me" signaling, homologous tumor targeting, and microfluidic elec...

Module 2 • Subtopic 3
Subtopic 1Document Lecture

Quantitative Systems Pharmacology (QSP) and Multi-Scale Ordinary Differential Equation (ODE) Biological Networks

Ph.D. in Pharmaceutical Sciences Chapter 3: PMSC 903: In Vivo Translational PK/PD & Mechanism-Based Systems Pharmacology Lecture 7 Quantitative Systems Pharmacology (QSP) and Multi-Scale Ordinary Differential Equation (ODE) Biological Networks Doctoral formulation of mechanistic mathematical models integrating drug exposure with complex biochemical signalling networks, receptor crosstalk, enzymati...

Module 3 • Subtopic 1
Subtopic 2Document Lecture

Mechanism-Based Target-Mediated Drug Disposition (TMDD) and Allosteric Modulator Kinetics

Ph.D. in Pharmaceutical Sciences Chapter 3: PMSC 903: In Vivo Translational PK/PD & Mechanism-Based Systems Pharmacology Lecture 8 Mechanism-Based Target-Mediated Drug Disposition (TMDD) and Allosteric Modulator Kinetics Doctoral analysis of non-linear pharmacokinetic clearance in biological therapeutics, full Mager-Krzyzanski TMDD model derivations, quasi-steady-state (QSS) and quasi-equilibrium...

Module 3 • Subtopic 2
Subtopic 3Document Lecture

Preclinical-to-Clinical Interspecies Allometric Scaling, First-in-Human Dose Selection, and MABEL Determinations

Ph.D. in Pharmaceutical Sciences Chapter 3: PMSC 903: In Vivo Translational PK/PD & Mechanism-Based Systems Pharmacology Lecture 9 Preclinical-to-Clinical Interspecies Allometric Scaling, First-in-Human Dose Selection, and MABEL Determinations Doctoral derivation of power-law allometric physiological scaling, Rule of Exponents correction, Human Equivalent Dose (HED) translation, NOAEL vs. MABEL sa...

Module 3 • Subtopic 3
Subtopic 1Document Lecture

High-Dimensional Transcriptomic, Proteomic, and Metabolomic Profiling in Drug Discovery

Ph.D. in Pharmaceutical Sciences Chapter 4: PMSC 904: High-Dimensional Biostatistics, Machine Learning & Multi-Omics Lecture 10 High-Dimensional Transcriptomic, Proteomic, and Metabolomic Profiling in Drug Discovery Doctoral investigation into next-generation RNA-Seq quantification, tandem mass tag (TMT) quantitative proteomics, untargeted metabolomic mass spectrometry, batch effect normalization,...

Module 4 • Subtopic 1
Formative Assessment10 Points • 15 Mins

Mid-Course Progress Assessment

Assessment Protocol:10 Total Points•70% Passing Threshold•15 Mins Time Limit•Bloom's Taxonomy: Analyze & Evaluate

Test your knowledge of Advanced Laboratory Methods (PhD Pharmacy)

Module 4 • Formative Assessment
Subtopic 3Document Lecture

Bayesian Hierarchical Modeling, Non-Linear Mixed Effects (NONMEM), and Population Pharmacokinetics

Ph.D. in Pharmaceutical Sciences Chapter 4: PMSC 904: High-Dimensional Biostatistics, Machine Learning & Multi-Omics Lecture 11 Bayesian Hierarchical Modeling, Non-Linear Mixed Effects (NONMEM), and Population Pharmacokinetics Doctoral formulation of non-linear mixed-effects (NLME) models, First-Order Conditional Estimation (FOCE-I), stochastic approximation expectation-maximization (SAEM), inter-...

Module 4 • Subtopic 3
Subtopic 4Document Lecture

Machine Learning Classification, Explainable AI (SHAP/LIME), and Multi-Omics Biomarker Identification

Ph.D. in Pharmaceutical Sciences Chapter 4: PMSC 904: High-Dimensional Biostatistics, Machine Learning & Multi-Omics Lecture 12 Machine Learning Classification, Explainable AI (SHAP/LIME), and Multi-Omics Biomarker Identification Doctoral formulation of supervised gradient boosted decision trees (XGBoost, LightGBM), deep neural networks, Shapley additive explanations (SHAP), and multi-omics biomar...

Module 4 • Subtopic 4
Subtopic 1Document Lecture

Cryo-Electron Microscopy (Cryo-EM) Sample Vitrification and Atomic-Resolution GPCR/Channel Reconstruction

Ph.D. in Pharmaceutical Sciences Chapter 5: PMSC 905: Advanced Bioanalytical Mass Spectrometry & Structural Biology Lecture 13 Cryo-Electron Microscopy (Cryo-EM) Sample Vitrification and Atomic-Resolution GPCR/Channel Reconstruction Doctoral investigation of cryo-vitrification biophysics, plunge-freezing in liquid ethane, contrast transfer function (CTF) deconvolution, single-particle 3D reconstru...

Module 5 • Subtopic 1
Subtopic 2Document Lecture

Native Mass Spectrometry, Ion Mobility Spectrometry, and Hydrogen-Deuterium Exchange Mass Spectrometry (HDX-MS)

Ph.D. in Pharmaceutical Sciences Chapter 5: PMSC 905: Advanced Bioanalytical Mass Spectrometry & Structural Biology Lecture 14 Native Mass Spectrometry, Ion Mobility Spectrometry, and Hydrogen-Deuterium Exchange Mass Spectrometry (HDX-MS) Doctoral analysis of non-covalent macromolecular gas-phase stability, nano-electrospray ionization (nESI), traveling wave ion mobility (TWIMS), collision cross s...

Module 5 • Subtopic 2
Subtopic 3Document Lecture

Ultra-High-Performance Liquid Chromatography Orbitrap Mass Spectrometry (UHPLC-HRMS) Bioanalysis Validation (ICH M10)

Ph.D. in Pharmaceutical Sciences Chapter 5: PMSC 905: Advanced Bioanalytical Mass Spectrometry & Structural Biology Lecture 15 Ultra-High-Performance Liquid Chromatography Orbitrap Mass Spectrometry (UHPLC-HRMS) Bioanalysis Validation (ICH M10) Doctoral mastery of regulatory bioanalytical method validation under ICH M10 harmonized standards, stable-isotope labeled internal standards (SIL-IS), matr...

Module 5 • Subtopic 3
Subtopic 4Open Access~3 min read

Mid-Semester Case Study & Research Paper

Sign in or enroll to access the full lecture notes and interactive reader.

Module 5 • Subtopic 4•132 characters of authentic academic content
Subtopic 1Document Lecture

Investigational New Drug (IND) Application Dossier Architecture (FDA 21 CFR 312 / EMA CTA Standards)

Ph.D. in Pharmaceutical Sciences Chapter 6: PMSC 906: Global Regulatory Science, Patent Law & Investigational New Drugs (IND) Lecture 16 Investigational New Drug (IND) Application Dossier Architecture (FDA 21 CFR 312 / EMA CTA Standards) Doctoral formulation of regulatory science dossiers, eCTD Module structure, Chemistry Manufacturing and Controls (CMC), GLP non-clinical toxicology programs (ICH...

Module 6 • Subtopic 1
Subtopic 2Document Lecture

Pharmaceutical Patent Prosecution, Freedom-to-Operate (FTO) Search, Hatch-Waxman Act, and BPCIA Framework

Ph.D. in Pharmaceutical Sciences Chapter 6: PMSC 906: Global Regulatory Science, Patent Law & Investigational New Drugs (IND) Lecture 17 Pharmaceutical Patent Prosecution, Freedom-to-Operate (FTO) Search, Hatch-Waxman Act, and BPCIA Framework Doctoral analysis of intellectual property architecture, patent claim drafting (Markush structures, polymorphs, formulations), Freedom-to-Operate (FTO) legal...

Module 6 • Subtopic 2
Subtopic 3Document Lecture

First-in-Human Phase 1 Clinical Protocol Design, Adaptive Dose-Escalation (CRM, 3+3, BOIN), and DSMB Oversight

Ph.D. in Pharmaceutical Sciences Chapter 6: PMSC 906: Global Regulatory Science, Patent Law & Investigational New Drugs (IND) Lecture 18 First-in-Human Phase 1 Clinical Protocol Design, Adaptive Dose-Escalation (CRM, 3+3, BOIN), and DSMB Oversight Doctoral formulation of Phase 1 clinical trial designs, Dose-Limiting Toxicity (DLT) definitions, Maximum Tolerated Dose (MTD), rule-based 3+3 designs v...

Module 6 • Subtopic 3
Subtopic 1Document Lecture

National Institutes of Health (NIH) R01 / Wellcome Trust Research Grant Proposal Architecture and Review Strategy

Ph.D. in Pharmaceutical Sciences Chapter 7: PMSC 907: Doctoral Research Pedagogy, Grant Writing & Academic Leadership Lecture 19 National Institutes of Health (NIH) R01 / Wellcome Trust Research Grant Proposal Architecture and Review Strategy Doctoral formulation of major extramural research grant applications, Specific Aims page design, NIH Center for Scientific Review (CSR) study section dynamic...

Module 7 • Subtopic 1
Subtopic 2Document Lecture

Bioethics in Advanced Translational Research, Stem Cell/Gene Editing Governance, and Authorship Ethics (COPE Standards)

Ph.D. in Pharmaceutical Sciences Chapter 7: PMSC 907: Doctoral Research Pedagogy, Grant Writing & Academic Leadership Lecture 20 Bioethics in Advanced Translational Research, Stem Cell/Gene Editing Governance, and Authorship Ethics (COPE Standards) Doctoral analysis of translational research ethics, somatic versus germline CRISPR-Cas9 genome editing, human pluripotent stem cell (hPSC) governance,...

Module 7 • Subtopic 2
Subtopic 3Document Lecture

Evidence-Based Postgraduate Pedagogy, Socratic Mentorship, and Laboratory Biosafety Management (BSL-2/3)

Ph.D. in Pharmaceutical Sciences Chapter 7: PMSC 907: Doctoral Research Pedagogy, Grant Writing & Academic Leadership Lecture 21 Evidence-Based Postgraduate Pedagogy, Socratic Mentorship, and Laboratory Biosafety Management (BSL-2/3) Doctoral formulation of academic leadership, cognitive load theory, Bloom's revised taxonomy, individual development plans (IDPs), Biosafety Level 2/3 containment, an...

Module 7 • Subtopic 3
Subtopic 1Document Lecture

Doctoral Dissertation Monograph Structuring: Epistemological Synthesis, Aims Integration, and Publication Portfolios

Ph.D. in Pharmaceutical Sciences Chapter 8: PMSC 908: Doctoral Dissertation Architecture, Scholarly Defense & Viva Voce Lecture 22 Doctoral Dissertation Monograph Structuring: Epistemological Synthesis, Aims Integration, and Publication Portfolios Doctoral formulation of dissertation architectures, traditional monolithic monograph versus stapler/cumulative publication-based dissertations, overarch...

Module 8 • Subtopic 1
Formative Assessment10 Points • 15 Mins

Comprehensive End-of-Course Examination

Assessment Protocol:10 Total Points•70% Passing Threshold•15 Mins Time Limit•Bloom's Taxonomy: Analyze & Evaluate

Test your knowledge of Doctoral Research Proposal Development (Pharmacy)

Module 8 • Formative Assessment
Subtopic 3Document Lecture

High-Impact Scholarly Publishing: Peer Review Response Protocols, Cover Letters, and Data Repository Deposition

Ph.D. in Pharmaceutical Sciences Chapter 8: PMSC 908: Doctoral Dissertation Architecture, Scholarly Defense & Viva Voce Lecture 23 High-Impact Scholarly Publishing: Peer Review Response Protocols, Cover Letters, and Data Repository Deposition Doctoral mastery of scientific journal submission, editor cover letters, peer review rebuttal diplomacy, point-by-point response matrices, open science data...

Module 8 • Subtopic 3
Subtopic 4Document Lecture

Doctoral Viva Voce Oral Defense Execution: Rigorous Scholarly Defense, Socratic Examination, and Post-Doctoral Transition

Ph.D. in Pharmaceutical Sciences Chapter 8: PMSC 908: Doctoral Dissertation Architecture, Scholarly Defense & Viva Voce Lecture 24 Doctoral Viva Voce Oral Defense Execution: Rigorous Scholarly Defense, Socratic Examination, and Post-Doctoral Transition Doctoral mastery of the final oral examination (Viva Voce), academic presentation architecture, defense strategies under hostile cross-examination,...

Module 8 • Subtopic 4

Instructor

PAMCET Learning Team

PAMCET Learning Team

Institutional Course Curation · PAMCET

The PAMCET Learning Team is the institutional curriculum and content group behind course publishing on this platform. PAMCET (Professional and Academic Management Centre for Education and Training) is operated by Digitpen Hub Ltd, a company registered in Lagos, Nigeria. Courses credited to the PAMCET Learning Team are structured, organized, and published centrally by the platform rather than authored by a single named individual instructor — each course's syllabus, learning outcomes, and content are reviewed before publication under this institutional account. For questions about a specific course or to report a content issue, please use the platform's Help & Support or Contact Us pages.

Qualifications:

PAMCET Learning Team — Institutional Course Curation, Digitpen Hub Ltd

My Skills:

  • Curriculum Curation
  • Course Content Review
  • Learning Outcome Design
  • Course Publishing & Quality Assurance
  • Platform Content Operations

Reviews

No reviews available
Ph.D. in Pharmaceutical Sciences: Molecular Pharmacology & Nanomedicine
Free$44.99100% Off
Certificate available separately for $7 after completion

Course Includes

8 Chapters
24 Lectures
1 week
Skill Level advanced
Taught in English
Lifetime Access
Certification of Completion
Category: University - Pharmacy
Share On

Download Syllabus & Study Guide

Receive the full lecture syllabus, reading list, and milestone schedule for Ph.D. in Pharmaceutical Sciences: Molecular Pharmacology & Nanomedicine.

By submitting, you agree to receive educational updates. You can unsubscribe anytime. Read our Privacy Policy.

Ph.D. in Pharmaceutical Sciences: Molecular Pharmacology & Nanomedicine — PhD | PAMCET